From the ODAC Poster Hall | Chronic Urticaria Exposure During Residency
Chronic urticaria is a common dermatologic condition, yet according to a recent survey, one in five clinicians deviates from known management guidelines. Researchers at the George Washington University (GWU) School of Medicine and Health Sciences Department of Dermatology surmised that the lack of confidence in workup and management of chronic urticaria and lack of adherence to guidelines may stem …
Chronic urticaria is a common dermatologic condition, yet according to a recent survey, one in five clinicians deviates from known management guidelines. Researchers at the George Washington University (GWU) School of Medicine and Health Sciences Department of Dermatology surmised that the lack of confidence in workup and management of chronic urticaria and lack of adherence to guidelines may stem … Continue reading "From the ODAC Poster Hall | Chronic Urticaria Exposure During Residency"
Antihistamines, particularly second-generation histamine H1-receptor antagonists, are widely used in dermatology due to their antihistaminic activity and favorable safety profile characterized by minimal sedation compared with first-generation agents. They primarily act as peripheral H1-receptor antagonists, reducing histamine-mediated effects such as vasodilation, increased vascular permeability, … 
At the 2026 ODAC Dermatology Conference, we had the privilege of learning about chronic spontaneous urticaria (CSU) from Dr. Adam Friedman, MD, FAAD, Professor and Chair of Dermatology at The George Washington University School of Medicine. CSU can be a maddening, exhausting condition for patients, with a relapsing disease course and without identifiable triggers. Given that symptoms are often abs … 
A 35-year-old female presents to dermatology clinic for the pictured rash, which has been recurring at least once per week for the past six months. Which of the following treatment options works by reducing mast cell degranulation through Bruton tyrosine kinase inhibition?
A. Dupilumab
B. Benralizumab
C. Cromolyn sodium
D. … 
Dermatologists need to be more visible in treating chronic spontaneous urticaria (CSU), says Dr. Adam Friedman, co-chair of the ODAC Dermatology, Aesthetic & Surgical Conference. Next Steps in Derm, in partnership with ODAC, interviewed Dr. Friedman, who shared what to consider when approaching a hive or hive-like patient. Hear the burden that patients with CSU face. Find out the first-line tr …